Browse by category

Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...

In one of the largest and longest real-world obesity studies to date that tracked nearly 2,700 adults over 64 weeks found patients...

About one in six European adults now live with obesity, putting them at greater risk for type 2 diabetes, heart disease and some...

The proportion of adolescents living with overweight or obesity in England has increased by 50% from 2008-2010 (22%) to 2021-2023 (33%),...

Weight loss programmes targeting a particular percentage of weight loss are often failing, and that other factors should be considered...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...

Women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and...

First generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss. Indeed,...

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrated positive preliminary data for...

A survey of adults living with obesity and their physicians across seven countries reveals a high disconnect between their perceptions...